Skip to main content

Advertisement

SpringerLink
Log in

Plasma copeptin for short term risk stratification in acute pulmonary embolism

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Copeptin (COP) was reported to have prognostic value in various cardiovascular diseases. We hypothesized that COP levels reflect the severity of acute pulmonary embolism (PE) and may be useful in prognostic assessment. Plasma COP concentrations were measured on the Kryptor Compact Plus platform (BRAHMS, Hennigsdorf, Germany). The study included 107 consecutive patients with diagnosed acute PE (47 males, 60 females), with median age of 65 years (range 20–88). High risk PE was diagnosed in 3 patients (2.8 %), intermediate risk in 69 (64.5 %), and low risk PE in 35 (32.7 %) patients. Control group included 64 subjects (25 males, 39 females; median age 52.5 year, range 17–87). Four patients (3.7 %) died during 30-day observation. Complicated clinical course (CCC) was experienced by 10 (9.3 %) patients. COP level was higher in PE patients than in controls [11.55 pmol/L (5.16–87.97), and 19.00 pmol/L (5.51–351.90), respectively, p < 0.0001], and reflected PE severity. COP plasma concentration in low risk PE was 14.67 nmol/L (5.51–59.61) and in intermediate/high risk PE 19.84 mol/L (5.64–351.90) p < 0.05. Median COP levels in nonsurvivors was higher than in survivors, 84.6 (28.48–351.9) pmol/L and 18.68 (5.512–210.1) pmol/L, respectively, p = 0.009. Subjects with CCC presented higher COP levels than patients with benign clinical course 53.1 (17.95–351.9) pmol/L and 18.16 (5.51–210.1) pmol/L, respectively, p = 0.001. Log-transformed plasma COP was the significant predictor of CCC, OR 16.5 95 % CI 23.2–111.9, p < 0.001. AUC—for prediction of CCC using plasma COP was 0.811 (95 % CI 0.676–0.927). The COP cut off value of 17.95 nmol/l had sensitivity of 100 %, specificity 49.5 %, positive predictive value of 16.9 % and negative predictive value of 100 %. We conclude that plasma COP levels can be regarded for promising marker of severity of acute PE and show potential in risk stratification of these patients.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Pruszczyk P, Bochowicz A, Kostrubiec M, Torbicki A, Szulc M, Gurba H, Kuczynska K, Berent H (2003) Myoglobin stratifies short-term risk in acute major pulmonary embolism. Clin Chim Acta 338(1–2):53–56

    Article  CAS  PubMed  Google Scholar 

  2. Lankeit M, Jimenez D, Kostrubiec M, Dellas C, Hasenfuss G, Pruszczyk P, Konstantinides S (2011) Predictive value of the high-sensitivity troponin T assay and the simplified Pulmonary Embolism Severity Index in hemodynamically stable patients with acute pulmonary embolism: a prospective validation study. Circulation 124(24):2716–2724. doi:10.1161/CIRCULATIONAHA.111.051177

    Article  CAS  PubMed  Google Scholar 

  3. Kostrubiec M, Pruszczyk P, Bochowicz A, Pacho R, Szulc M, Kaczynska A, Styczynski G, Kuch-Wocial A, Abramczyk P, Bartoszewicz Z, Berent H, Kuczynska K (2005) Biomarker-based risk assessment model in acute pulmonary embolism. Eur Heart J 26(20):2166–2172. doi:10.1093/eurheartj/ehi336

    Article  CAS  PubMed  Google Scholar 

  4. Konstantinides S, Goldhaber SZ (2012) Pulmonary embolism: risk assessment and management. Eur Heart J 33(24):3014–3022. doi:10.1093/eurheartj/ehs258

    Article  CAS  PubMed  Google Scholar 

  5. Torbicki A (2014) Prognostic staging of acute pulmonary embolism: are we closer to the holy grail? Eur Respir J 44(3):565–567. doi:10.1183/09031936.00072714

    Article  PubMed  Google Scholar 

  6. Lipinski MJ, Escarcega RO, D’Ascenzo F, Magalhaes MA, Baker NC, Torguson R, Chen F, Epstein SE, Miro O, Llorens P, Giannitsis E, Lotze U, Lefebvre S, Sebbane M, Cristol JP, Chenevier-Gobeaux C, Meune C, Eggers KM, Charpentier S, Twerenbold R, Mueller C, Biondi-Zoccai G, Waksman R (2014) A systematic review and collaborative meta-analysis to determine the incremental value of copeptin for rapid rule-out of acute myocardial infarction. Am J Cardiol 113(9):1581–1591. doi:10.1016/j.amjcard.2014.01.436

    Article  CAS  PubMed  Google Scholar 

  7. Mockel M, Searle J, Hamm C, Slagman A, Blankenberg S, Huber K, Katus H, Liebetrau C, Muller C, Muller R, Peitsmeyer P, von Recum J, Tajsic M, Vollert JO, Giannitsis E (2015) Early discharge using single cardiac troponin and copeptin testing in patients with suspected acute coronary syndrome (ACS): a randomized, controlled clinical process study. Eur Heart J 36(6):369–376. doi:10.1093/eurheartj/ehu178

    Article  PubMed  PubMed Central  Google Scholar 

  8. Yu WH, Wang WH, Dong XQ, Du Q, Yang DB, Shen YF, Wang H, Zhang ZY, Zhu Q, Che ZH, Liu QJ, Jiang L, Du YF (2014) Prognostic significance of plasma copeptin detection compared with multiple biomarkers in intracerebral hemorrhage. Clin Chim Acta 433:174–178. doi:10.1016/j.cca.2014.03.014

    Article  CAS  PubMed  Google Scholar 

  9. Pozsonyi Z, Forhecz Z, Gombos T, Karadi I, Janoskuti L, Prohaszka Z (2014) Copeptin (C-terminal pro arginine-vasopressin) is an independent long-term prognostic marker in heart failure with reduced ejection fraction. Heart Lung Circ. doi:10.1016/j.hlc.2014.10.008

    PubMed  Google Scholar 

  10. Jiang L, Feng B, Gao D, Zhang Y (2015) Plasma concentrations of copeptin, C-reactive protein and procalcitonin are positively correlated with APACHE II scores in patients with sepsis. J Int Med Res. 43(2):188–195. doi:10.1177/0300060514561136

    Article  CAS  PubMed  Google Scholar 

  11. Ray P, Charpentier S, Chenevier-Gobeaux C, Reichlin T, Twerenbold R, Claessens YE, Jourdain P, Riou B, Mueller C (2012) Combined copeptin and troponin to rule out myocardial infarction in patients with chest pain and a history of coronary artery disease. Am J Emerg Med 30(3):440–448. doi:10.1016/j.ajem.2011.12.008

    Article  PubMed  Google Scholar 

  12. Iversen K, Gotze JP, Dalsgaard M, Nielsen H, Boesgaard S, Bay M, Kirk V, Nielsen OW, Kober L (2014) Risk stratification in emergency patients by copeptin. BMC Med 12:80. doi:10.1186/1741-7015-12-80

    Article  PubMed  PubMed Central  Google Scholar 

  13. Pruszczyk P, Goliszek S, Lichodziejewska B, Kostrubiec M, Ciurzynski M, Kurnicka K, Dzikowska-Diduch O, Palczewski P, Wyzgal A (2014) Prognostic value of echocardiography in normotensive patients with acute pulmonary embolism. JACC Cardiovasc Imaging 7(6):553–560. doi:10.1016/j.jcmg.2013.11.004

    Article  PubMed  Google Scholar 

  14. Konstantinides SV, Torbicki A, Agnelli G, Danchin N, Fitzmaurice D, Galie N, Gibbs JS, Huisman MV, Humbert M, Kucher N, Lang I, Lankeit M, Lekakis J, Maack C, Mayer E, Meneveau N, Perrier A, Pruszczyk P, Rasmussen LH, Schindler TH, Svitil P, Vonk Noordegraaf A, Zamorano JL, Zompatori M; Task Force for the D, Management of Acute Pulmonary Embolism of the European Society of C (2014) 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism. Eur Heart J 35 (43):3033–3069, 3069a–3069k. doi:10.1093/eurheartj/ehu283

  15. Heinze G, Puhr R (2010) Bias-reduced and separation-proof conditional logistic regression with small or sparse data sets. Stat Med 29(7–8):770–777. doi:10.1002/sim.3794

    Article  PubMed  Google Scholar 

  16. Lankeit M, Jimenez D, Kostrubiec M, Dellas C, Kuhnert K, Hasenfuss G, Pruszczyk P, Konstantinides S (2014) Validation of N-terminal pro-brain natriuretic peptide cut-off values for risk stratification of pulmonary embolism. Eur Respir J 43(6):1669–1677. doi:10.1183/09031936.00211613

    Article  CAS  PubMed  Google Scholar 

  17. Pedowska-Wloszek J, Kostrubiec M, Kurnicka K, Ciurzynski M, Palczewski P, Pruszczyk P (2013) Midregional proadrenomedullin (MR-proADM) in the risk stratification of patients with acute pulmonary embolism. Thromb Res 132(5):506–510. doi:10.1016/j.thromres.2013.08.008

    Article  CAS  PubMed  Google Scholar 

  18. Gegenhuber A, Struck J, Dieplinger B, Poelz W, Pacher R, Morgenthaler NG, Bergmann A, Haltmayer M, Mueller T (2007) Comparative evaluation of B-type natriuretic peptide, mid-regional pro-A-type natriuretic peptide, mid-regional pro-adrenomedullin, and Copeptin to predict 1-year mortality in patients with acute destabilized heart failure. J Card Fail 13(1):42–49. doi:10.1016/j.cardfail.2006.09.004

    Article  CAS  PubMed  Google Scholar 

  19. O’Malley RG, Bonaca MP, Scirica BM, Murphy SA, Jarolim P, Sabatine MS, Braunwald E, Morrow DA (2014) Prognostic performance of multiple biomarkers in patients with non-ST-segment elevation acute coronary syndrome: analysis from the MERLIN-TIMI 36 trial (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Elevation Acute Coronary Syndromes-Thrombolysis In Myocardial Infarction 36). J Am Coll Cardiol 63(16):1644–1653. doi:10.1016/j.jacc.2013.12.034

    Article  PubMed  Google Scholar 

  20. Geri G, Dumas F, Chenevier-Gobeaux C, Bougle A, Daviaud F, Morichau-Beauchant T, Jouven X, Mira JP, Pene F, Empana JP, Cariou A (2015) Is copeptin level associated with 1-year mortality after out-of-hospital cardiac arrest? Insights from the Paris registry*. Crit Care Med 43(2):422–429. doi:10.1097/CCM.0000000000000716

    Article  CAS  PubMed  Google Scholar 

  21. Maisel A, Xue Y, Shah K, Mueller C, Nowak R, Peacock WF, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Clopton P, Filippatos GS, Di Somma S, Anand IS, Ng L, Daniels LB, Neath SX, Christenson R, Potocki M, McCord J, Terracciano G, Kremastinos D, Hartmann O, von Haehling S, Bergmann A, Morgenthaler NG, Anker SD (2011) Increased 90-day mortality in patients with acute heart failure with elevated copeptin: secondary results from the Biomarkers in Acute Heart Failure (BACH) study. Circ Heart Fail 4(5):613–620. doi:10.1161/CIRCHEARTFAILURE.110.960096

    Article  CAS  PubMed  Google Scholar 

  22. Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, Mueller C, Ponikowski P, Mockel M, Hogan C, Wu AH, Richards M, Filippatos GS, Anand I, Ng LL, Daniels LB, Morgenthaler N, Anker SD, Maisel AS (2011) Short-term mortality risk in emergency department acute heart failure. Acad Emerg Med 18(9):947–958. doi:10.1111/j.1553-2712.2011.01150.x

    Article  PubMed  Google Scholar 

  23. Maisel A, Mueller C, Neath SX, Christenson RH, Morgenthaler NG, McCord J, Nowak RM, Vilke G, Daniels LB, Hollander JE, Apple FS, Cannon C, Nagurney JT, Schreiber D, deFilippi C, Hogan C, Diercks DB, Stein JC, Headden G, Limkakeng AT Jr, Anand I, Wu AH, Papassotiriou J, Hartmann O, Ebmeyer S, Clopton P, Jaffe AS, Peacock WF (2013) Copeptin helps in the early detection of patients with acute myocardial infarction: primary results of the CHOPIN trial (Copeptin Helps in the early detection Of Patients with acute myocardial INfarction). J Am Coll Cardiol 62(2):150–160. doi:10.1016/j.jacc.2013.04.011

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine and Cardiology, The Medical University of Warsaw, Lindleya 4, 02-005, Warsaw, Poland

    Anna Wyzgał, Marcin Koć, Szymon Pacho, Radosław Wawrzyniak, Maciej Kostrubiec, Michał Ciurzyński, Katarzyna Kurnicka, Sylwia Goliszek, Marzena Paczyńska & Piotr Pruszczyk

  2. Department of Psychology, University of Social Sciences and Humanities, Warsaw, Poland

    Maksymilian Bielecki

  3. Department of Radiology, Medical University of Warsaw, Warsaw, Poland

    Piotr Palczewski

Authors
  1. Anna Wyzgał
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Marcin Koć
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Szymon Pacho
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Maksymilian Bielecki
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Radosław Wawrzyniak
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Maciej Kostrubiec
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Michał Ciurzyński
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Katarzyna Kurnicka
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Sylwia Goliszek
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Marzena Paczyńska
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Piotr Palczewski
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Piotr Pruszczyk
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Piotr Pruszczyk.

Ethics declarations

Conflict of interest

None declared.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Wyzgał, A., Koć, M., Pacho, S. et al. Plasma copeptin for short term risk stratification in acute pulmonary embolism. J Thromb Thrombolysis 41, 563–568 (2016). https://doi.org/10.1007/s11239-015-1284-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-015-1284-5

Keywords

Search

Navigation